Why Eli Lilly Topped the Market Today
8 Articles
8 Articles
Here you will find information on the topic "Pharmaceuticals". Read now "Despite billions of strokes: Eli-Lilly plant Alzey in the plan".
Pharma and Biotech Stocks in the Spotlight: Moderna, BioNxt Solutions, and Eli Lilly
Eli Lilly: Profits Remain Strong At Eli Lilly, many investors are keeping an eye on news regarding weight-loss injections. And there is certainly a lot happening here. The pharmaceutical company has received approval for its obesity drug in tablet form and has generated initial revenue of nearly USD 100 million. According to management, there has been virtually no cannibalization of sales from its own weight-loss injections. In addition, the com…
Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocks
InvestorPlace - Stock Market News, Stock Advice & Trading Tips During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. The post Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocks appeared first on InvestorPlace.
Due to the German government's healthcare budget cuts, Eli Lilly halved its planned billion-dollar investment in a new site in Alzey, Rhineland-Palatinate. However, the US pharmaceutical company intends to proceed with the opening next year.
The billions investment in the pharmaceutical site was intended to create 1,000 jobs in Rhineland-Palatinate. The US pharmaceutical group maintains its goals in a molten form.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium










